Beam Therapeutics Inc - BEAM Earnings per share for the trailing year

Public company logo of Beam Therapeutics Corp (BEAM)

Patents for precise DNA modification create a powerful defensive barrier against new entrants. This attracts leading molecular biologists seeking to eradicate hereditary pathologies in cutting-edge laboratories. The current YoY EPS shift over the last 12 months demonstrates profit dynamics, where 78.10 is the current level of the indicator. Intellectual capital and RSU programs allow Beam Therapeutics Inc. (BEAM) to retain the elite of global genetics.

beamtx.com (BEAM): Earnings per share for the last twelve months from 02/11/2024 to 11/18/2026

BEAM (Beam Therapeutics Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Fundamental company valuation:BEAM, Beam Therapeutics Corp
Mass-produced product of Beam Therapeutics Inc

Beam Therapeutics Inc. (BEAM) leadership in base editing and the platform's patent protection establish the foundation for future profit growth. Analyzing the YoY change in EPS on a rolling 12-month basis allows for an assessment of how the company's prospects are being discounted through the annual transformation of net income, helping investors identify the momentum phase and avoid purchasing the asset at the peak of the market cycle.

Direct competitors

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Earnings per share for the trailing year SRPT|twistbioscience.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TXG (10x Genomics, Inc.)|NTLA: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months STOK (Stoke Therapeutics, Inc.)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months IMNN|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX